What are the major opportunities in the Biologics CDMO market? What are the strategies for the Biologics CDMO market?

For detailed insights on the major opportunities and strategies in the Biologics CDMO market, Read More

How does the Biologics CDMO market relate to the overall economy and other similar markets?

For detailed insights on Biologics CDMO's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Biologics CDMO market growth? SWOT analysis of the Biologics CDMO market.

For detailed insights on the key dynamics influencing the Biologics CDMO market growth and SWOT analysis of the Biologics CDMO industry, Read More

Biologics CDMO Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Biologics CDMO Market Report 2026

Name: Biologics CDMO Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Cell Type (Mammalian, Non-Mammalian), By Product Type (Biologics, Biosimilars), By Service Type (Drug Substance Manufacturing, Drug Product (Fill–Finish) Manufacturing, Process Development, Analytical & Quality Testing Services) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Biologics CDMO Market Overview

• Biologics CDMO market size has reached to $24.15 billion in 2025

• Expected to grow to $48.07 billion in 2030 at a compound annual growth rate (CAGR) of 14.9%

• Growth Driver: Rise In Demand For Cell And Genetic Therapy Fuels Biologics CDMO Market Growth

• Market Trend: Advancements In Biologics CDMO

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biologics CDMO Market?

A biologics contract development and manufacturing organization (CDMO) is a service provider that supports pharmaceutical companies in the development and production of biologic drugs, which include vaccines, blood and blood components, allergens, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins.

The main cell types in biologics CDMO are mammalian and non-mammalian. Mammalian refers to cell lines derived from mammals, commonly used in the production of biologics and cell-based therapies due to their ability to produce complex proteins and maintain post-translational modifications. The various products types include biologics and biosimilars.

Biologics CDMO Market Global Report 2026 Market Report bar graph

What Is The Biologics CDMO Market Size and Share 2026?

The biologics cdmo market size has grown rapidly in recent years. It will grow from $24.15 billion in 2025 to $27.56 billion in 2026 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to rise in biologics research, advancements in cell culture technologies, increasing prevalence of chronic diseases, growth of biosimilar pipelines, government support for biopharma manufacturing.

What Is The Biologics CDMO Market Growth Forecast?

The biologics cdmo market size is expected to see rapid growth in the next few years. It will grow to $48.07 billion in 2030 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to surge in gene and cell therapy development, adoption of automation and robotics in CDMO processes, expansion of global biologics manufacturing capacity, increasing investment in precision medicine, rising demand for cost-effective biologics. Major trends in the forecast period include expansion of biologics cdmo services, growth in mammalian cell-based production, increase in outsourcing of gene therapy manufacturing, adoption of advanced bioprocessing techniques, rising demand for biosimilars.

Book your 30 minutes free consultation with our research experts

Global Biologics CDMO Market Segmentation

1) By Cell Type: Mammalian, Non-Mammalian

2) By Product Type: Biologics, Biosimilars

3) By Service Type: Drug Substance Manufacturing, Drug Product (Fill–Finish) Manufacturing, Process Development, Analytical & Quality Testing Services

Subsegments:

1) By Mammalian: Chinese Hamster Ovary (CHO) Cells, Human Embryonic Kidney (HEK) Cells, Other Mammalian Cells

2) By Non-Mammalian: Yeast Cells, Bacterial Cells, Insect Cells, Other Non-Mammalian Cells

What Is The Driver Of The Biologics CDMO Market?

The surge in demand for cell and genetic therapy is expected to propel the growth of the biologic CDMO market going forward. Cell and gene therapy are innovative medical approaches that utilize living cells or genetic material to address underlying disease causes at the cellular or genetic level, providing potential treatments for conditions that are difficult to manage or incurable with traditional pharmaceuticals. The demand for cell and gene therapy is rising due to their potential to offer innovative treatments for diseases by addressing underlying genetic or cellular causes. Biologic CDMOs provide expertise in handling living cells, viral vectors, and genetic material, facilitating safe and efficient production of cell and gene therapies while assisting biopharmaceutical companies in navigating regulatory requirements and technical challenges, thereby facilitating translation from research to clinical application. For instance, in March 2024, according to the IQVIA Holdings Inc., a US-based provider of advanced analytics, technology solutions, and clinical research services for the life sciences and healthcare industries, global spending on cell and gene therapies surged to $5.9 billion in 2023, an increase of 38% from 2022. Therefore, the surge in demand for cell and genetic therapy is driving the growth of the biologic CDMO market.

Key Players In The Global Biologics CDMO Market

Major companies operating in the biologics cdmo market are Lonza Group Ltd, Samsung Biologics Co Ltd, WuXi Biologics Cayman Inc, Catalent Inc, Thermo Fisher Scientific Inc, Boehringer Ingelheim International GmbH, Emergent BioSolutions Inc, Grifols SA, AbbVie Inc, Novartis AG, Sandoz International GmbH, Fujifilm Holdings Corporation, AGC Inc, JSR Corporation, Shenzhen Hepalink Pharmaceutical Co Ltd, Kemwell Biopharma Pvt Ltd, Bora Pharmaceuticals Co Ltd, Binex Co Ltd, 3P Biopharmaceuticals SLU, Cytovance Biologics

Global Biologics CDMO Market Trends and Insights

Major companies operating in the biologics CDMO market are developing technologically advanced solutions, such as new cell lines, to enhance biopharmaceutical development and manufacturing efficiency and capabilities. The technology produces therapeutic antibodies with enhanced potency, addressing immunotherapy research and development challenges. For instance, in November 2023, Lonza Group, a Switzerland-based manufacturing company that specializes in the pharmaceutical and biotechnology sectors, launched GS Effex cell lines, designed to produce antibodies that are 100% free of fucose, a sugar molecule and demonstrate increased potency without compromising on other performance attributes. It helps overcome immunotherapy research and development challenges related to the need for antibody therapeutics to increase potency. It is a stable, scalable, and productive cell line that provides a solution for therapeutic development from discovery-stage research through commercial manufacturing.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Biologics CDMO Market?

In December 2024, Novo Holdings A/S, a Denmark-based investment company, completed the acquisition of Catalent, Inc., for an undisclosed amount. With this acquisition, Novo Holdings aims to strengthen its portfolio in the contract development and manufacturing organization (CDMO) sector, enhance global manufacturing capabilities, and support the expansion of innovative drug development solutions. Catalent, Inc., is a US-based CDMO that provides advanced delivery technologies, development, and manufacturing services for drugs, biologics, and consumer health products.

Regional Insights

North America was the largest region in the biologics CDMO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Biologics CDMO Market?

The biologics CDMO market consist of revenues earned by entities by providing services such as process development, analytical development, cell line development, supply chain management, and fill-finish services. The biologics CDMO market also includes sales of monoclonal antibodies, recombinant proteins, antisense and molecular therapy, and vaccines. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Biologics CDMO Market Report 2026?

The biologics cdmo market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biologics cdmo industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Biologics CDMO Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$27.56 billion
Revenue Forecast In 2035	$48.07 billion
Growth Rate	CAGR of 14.1% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Cell Type, Product Type, Service Type
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Lonza Group Ltd, Samsung Biologics Co Ltd, WuXi Biologics Cayman Inc, Catalent Inc, Thermo Fisher Scientific Inc, Boehringer Ingelheim International GmbH, Emergent BioSolutions Inc, Grifols SA, AbbVie Inc, Novartis AG, Sandoz International GmbH, Fujifilm
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Biologics CDMO Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Biologics CDMO Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Biologics CDMO Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Biologics CDMO Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Biotechnology, Genomics & Precision Medicine

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Expansion Of Biologics Cdmo Services

4.2.2 Growth In Mammalian Cell-Based Production

4.2.3 Increase In Outsourcing Of Gene Therapy Manufacturing

4.2.4 Adoption Of Advanced Bioprocessing Techniques

4.2.5 Rising Demand For Biosimilars

5. Biologics CDMO Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies

5.2 Biotechnology Companies

5.3 Research Institutions

5.4 Contract Manufacturing Organizations

5.5 Hospitals & Clinics

6. Biologics CDMO Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Biologics CDMO Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Biologics CDMO PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Biologics CDMO Market Size, Comparisons And Growth Rate Analysis

7.3. Global Biologics CDMO Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Biologics CDMO Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Biologics CDMO Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Biologics CDMO Market Segmentation

9.1. Global Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Mammalian, Non-Mammalian

9.2. Global Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Biologics, Biosimilars

9.3. Global Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Drug Substance Manufacturing, Drug Product (Fill–Finish) Manufacturing, Process Development, Analytical & Quality Testing Services

9.4. Global Biologics CDMO Market, Sub-Segmentation Of Mammalian, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chinese Hamster Ovary (CHO) Cells, Human Embryonic Kidney (HEK) Cells, Other Mammalian Cells

9.5. Global Biologics CDMO Market, Sub-Segmentation Of Non-Mammalian, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Yeast Cells, Bacterial Cells, Insect Cells, Other Non-Mammalian Cells

10. Biologics CDMO Market Regional And Country Analysis

10.1. Global Biologics CDMO Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Biologics CDMO Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Biologics CDMO Market

11.1. Asia-Pacific Biologics CDMO Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Biologics CDMO Market

12.1. China Biologics CDMO Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Biologics CDMO Market

13.1. India Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Biologics CDMO Market

14.1. Japan Biologics CDMO Market Overview

14.2. Japan Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Biologics CDMO Market

15.1. Australia Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Biologics CDMO Market

16.1. Indonesia Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Biologics CDMO Market

17.1. South Korea Biologics CDMO Market Overview

17.2. South Korea Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Biologics CDMO Market

18.1. Taiwan Biologics CDMO Market Overview

18.2. Taiwan Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Biologics CDMO Market

19.1. South East Asia Biologics CDMO Market Overview

19.2. South East Asia Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Biologics CDMO Market

20.1. Western Europe Biologics CDMO Market Overview

20.2. Western Europe Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Biologics CDMO Market

21.1. UK Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Biologics CDMO Market

22.1. Germany Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Biologics CDMO Market

23.1. France Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Biologics CDMO Market

24.1. Italy Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Biologics CDMO Market

25.1. Spain Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Biologics CDMO Market

26.1. Eastern Europe Biologics CDMO Market Overview

26.2. Eastern Europe Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Biologics CDMO Market

27.1. Russia Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Biologics CDMO Market

28.1. North America Biologics CDMO Market Overview

28.2. North America Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Biologics CDMO Market

29.1. USA Biologics CDMO Market Overview

29.2. USA Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Biologics CDMO Market

30.1. Canada Biologics CDMO Market Overview

30.2. Canada Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Biologics CDMO Market

31.1. South America Biologics CDMO Market Overview

31.2. South America Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Biologics CDMO Market

32.1. Brazil Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Biologics CDMO Market

33.1. Middle East Biologics CDMO Market Overview

33.2. Middle East Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Biologics CDMO Market

34.1. Africa Biologics CDMO Market Overview

34.2. Africa Biologics CDMO Market, Segmentation By Cell Type, Segmentation By Product Type, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Biologics CDMO Market Regulatory and Investment Landscape

36. Biologics CDMO Market Competitive Landscape And Company Profiles

36.1. Biologics CDMO Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Biologics CDMO Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Biologics CDMO Market Company Profiles

36.3.1. Lonza Group Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Samsung Biologics Co Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.3. WuXi Biologics Cayman Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Catalent Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis

37. Biologics CDMO Market Other Major And Innovative Companies

Boehringer Ingelheim International GmbH, Emergent BioSolutions Inc, Grifols SA, AbbVie Inc, Novartis AG, Sandoz International GmbH, Fujifilm Holdings Corporation, AGC Inc, JSR Corporation, Shenzhen Hepalink Pharmaceutical Co Ltd, Kemwell Biopharma Pvt Ltd, Bora Pharmaceuticals Co Ltd, Binex Co Ltd, 3P Biopharmaceuticals SLU, Cytovance Biologics

38. Global Biologics CDMO Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Biologics CDMO Market

40. Biologics CDMO Market High Potential Countries, Segments and Strategies

40.1 Biologics CDMO Market In 2030 - Countries Offering Most New Opportunities

40.2 Biologics CDMO Market In 2030 - Segments Offering Most New Opportunities

40.3 Biologics CDMO Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Biologics CDMO Market, Overview Of Key Products - Product Examples

Table 2: Global Biologics CDMO Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Biologics CDMO Market, Supply Chain Analysis

Table 4: Global Biologics CDMO Market, Major Raw Material Providers

Table 5: Global Biologics CDMO Market, Major Resource Providers

Table 6: Global Biologics CDMO Market, Major Manufacturers (Suppliers)

Table 7: Global Biologics CDMO Market, Major Distributors And Channel Partners

Table 8: Global Biologics CDMO Market, Key Technologies & Future Trends

Table 9: Global Biologics CDMO Market, Major Trends

Table 10: Global Biologics CDMO Market, Major End Users

Table 11: Global Biologics CDMO Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Biologics CDMO Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Biologics CDMO Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Biologics CDMO Market - TAM, US$ Billion, 2025

Table 15: Global Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Biologics CDMO Market, Sub-Segmentation Of Mammalian, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Biologics CDMO Market, Sub-Segmentation Of Non-Mammalian, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Biologics CDMO Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Biologics CDMO Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Indonesia, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: South Korea, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Taiwan, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South East Asia, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Western Europe, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: UK, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Germany, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: France, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Italy, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Spain, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Eastern Europe, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Russia, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: North America, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: USA, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: Canada, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: South America, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Brazil, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Middle East, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Africa, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Global Biologics CDMO Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 95: Global Biologics CDMO Market - Company Scoring Matrix

Table 96: Lonza Group Ltd Financial Performance

Table 97: Samsung Biologics Co Ltd Financial Performance

Table 98: WuXi Biologics Cayman Inc Financial Performance

Table 99: Catalent Inc Financial Performance

Table 100: Thermo Fisher Scientific Inc Financial Performance

Table 101: Global Biologics CDMO Market, Competitive Benchmarking (In USD Billions)

Table 102: Global Biologics CDMO Market, Competitive Dashboard

Table 103: Global Biologics CDMO Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 104: Global, Biologics CDMO Market Size Gain ($ Billion), Segmentation By Cell Type, 2025 – 2030

Table 105: Global, Biologics CDMO Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Table 106: Global, Biologics CDMO Market Size Gain ($ Billion), Segmentation By Service Type, 2025 – 2030

List Of Figures

Figure 1: Global Biologics CDMO Market, Overview Of Key Products - Product Examples

Figure 2: Global Biologics CDMO Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Biologics CDMO Market, Supply Chain Analysis

Figure 4: Global Biologics CDMO Market, Major Raw Material Providers

Figure 5: Global Biologics CDMO Market, Major Resource Providers

Figure 6: Global Biologics CDMO Market, Major Manufacturers (Suppliers)

Figure 7: Global Biologics CDMO Market, Major Distributors And Channel Partners

Figure 8: Global Biologics CDMO Market, Key Technologies & Future Trends

Figure 9: Global Biologics CDMO Market, Major Trends

Figure 10: Global Biologics CDMO Market, Major End Users

Figure 11: Global Biologics CDMO Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Biologics CDMO Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Biologics CDMO Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Biologics CDMO Market - TAM, US$ Billion, 2025

Figure 15: Global Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Biologics CDMO Market, Sub-Segmentation Of Mammalian, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Biologics CDMO Market, Sub-Segmentation Of Non-Mammalian, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Biologics CDMO Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Biologics CDMO Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Indonesia, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: South Korea, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Taiwan, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South East Asia, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Western Europe, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: UK, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Germany, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: France, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Italy, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Spain, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Eastern Europe, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Russia, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: North America, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: USA, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: Canada, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: South America, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Brazil, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Middle East, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Africa, Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Biologics CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Global Biologics CDMO Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 95: Global Biologics CDMO Market - Company Scoring Matrix

Figure 96: Lonza Group Ltd Financial Performance

Figure 97: Samsung Biologics Co Ltd Financial Performance

Figure 98: WuXi Biologics Cayman Inc Financial Performance

Figure 99: Catalent Inc Financial Performance

Figure 100: Thermo Fisher Scientific Inc Financial Performance

Figure 101: Global Biologics CDMO Market, Competitive Benchmarking (In USD Billions)

Figure 102: Global Biologics CDMO Market, Competitive Dashboard

Figure 103: Global Biologics CDMO Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 104: Global, Biologics CDMO Market Size Gain ($ Billion), Segmentation By Cell Type, 2025 – 2030

Figure 105: Global, Biologics CDMO Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Figure 106: Global, Biologics CDMO Market Size Gain ($ Billion), Segmentation By Service Type, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Personalized Beauty Devices Market Report 2026 - Global Outlook – By Product (Skin Care, Make-Up), By Service (At-Home, In-Store), By Sales Channel (Direct Sales, Departmental Stores, Specialty Stores, Online Retailers, ...

Automotive Glass Replacement Market Report 2026 - Global Outlook – By Product (Tempered, Laminated), By Vehicle Type (Passenger Car, Heavy Commercial), By Application (Windscreen, Backlite, Sidelite, Sunroof, Other Appli...

Polyphenylene Market Report 2026 - Global Outlook – By Type (Polyphenylene Sulfide(PPS), Polyphenylene Ether Or Oxide(PPE Or PPO)), By Application (Composites, Engineering Plastics, Filter Bags, Other Applications ), By ...

Industrial Margarine Market Report 2026 - Global Outlook – By Product (Spreadable, All-Purpose, Liquid, Other Products), By Form (Hard, Soft), By Application (Bakery, Confectionery, Toppings, Sauces, And Spreads, Conveni...

Platelet Aggregation Devices Market Report 2026 - Global Outlook – By Product (Reagents, Systems, Consumables And Accessories), By Channel Configuration (Four Channel, Dual Channel, Eight Channel), By Technology (Optical...

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Report 2026 - Global Outlook – By Type (Contract Manufacturing Services, Contract Research Services), By Research Phase (Preclinical, Phase ...

Frequently Asked Questions

How big is the Biologics CDMO Market?

The Biologics CDMO market was valued at $24.15 billion in 2025, increased to $27.56 billion in 2026, and is projected to reach $48.07 billion by 2030.

What is the Biologics CDMO market growth?

The global Biologics CDMO market is expected to grow at a CAGR of 14.9% from 2026 to 2035 to reach $48.07 billion by 2035.

Who are the key players in Biologics CDMO market?

Some Key Players in the Biologics CDMO market Include, Lonza Group Ltd, Samsung Biologics Co Ltd, WuXi Biologics Cayman Inc, Catalent Inc, Thermo Fisher Scientific Inc, Boehringer Ingelheim International GmbH, Emergent BioSolutions Inc, Grifols SA, Ab

Major trend in this market includes: Advancements In Biologics CDMO. For further insights on this market. request a sample here

North America was the largest region in the biologics CDMO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologics cdmo market report are Asia-Pacific, South East

Book your 30 minutes free consultation with our research experts

Contact Us